Christopher Viehbacher, ex-CEO of Sanofi, has been appointed as the managing partner of Waypoint Capital's US-based fund, Gurnet Point Capital. Waypoint is the investment vehicle of the Bertarelli family, former owners of Serono, which was sold to Merck KGaA of Germany in 2007 in a deal worth around €10bn. Waypoint's chairman is Ernesto Bertarelli, the former CEO of Serono.
Founded in 2013 by Waypoint and Fereydoun Firouz (the former head of Merck Serono US), GPC has an initial allocation...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
